Abstract:Key PointsInnate lymphoid cells (ILCs) are newly identified members of the lymphoid lineage with emerging roles in mediating immune responses and in regulating tissue homeostasis and inflammation.The existence of different ILC populations that can rapidly secrete immunoregulatory cytokines suggests that these cells may have evolved to provide immunity to infections. Indeed, it is notable that ILC subsets seem to be particularly prevalent at mucosal surfaces, which are constantly exposed to infectious agents in the external environment.The group 1 ILC lineage comprises ILCs such as natural killer (NK) cells that produce type 1 cytokines, notably interferon-γ and tumour necrosis factor. Other group 1 ILCs have been reported, mainly in vitro, and their physiological roles remain to be defined.The group 2 ILC population comprises ILC2s, which express interleukin-5 (IL-5) and IL-13 and require GATA-binding protein 3 (GATA3) and retinoic acid receptor-related orphan receptor-α (RORα) for their development. They have crucial roles in protective type 2 immunity to helminth infection. Furthermore, although T helper 2 cells are a major source of type 2 cytokines during allergic asthma, ILC2s also contribute to disease pathology.ILC3s were first defined as intestinal lymphoid cells that express the NK cell activating receptor NKp46, but otherwise bear little functional resemblance to conventional NK cells, and require RORγ for their development. They express IL-17A and IL-22.Recent studies have also implicated ILC3s in the development of inflammatory bowel disease. Studies in Rag2−/− mice demonstrated that, in the early phase of Citrobacter rodentium infection, IL-22 is produced from an innate cell source.Lymphoid tissue-inducer (LTi) cells are an ILC subset that appears to be closely related to ILC3s, but their exact relationship remains controversial. Together, LTi cells and ILC3s have been classified as group 3 ILCs.

Differential Role of Id2 in the Group 3 Innate Lymphoid Cells for the Development of Different Gut Associated Lymphoid Tissues

The Role of ILC3 in Intestinal Immunity

Innate lymphoid cells protect host against intestinal pathogen through Id2 dependent IL-22 production and regulation of microbiota. (MUC4P.855)

ILC2 Proliferated by IL-33 Stimulation Alleviates Acute Colitis in Rag1-/- Mouse through Promoting M2 Macrophage Polarization

Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota

Innate lymphoid cells — how did we miss them?

Reciprocal transcription factor networks govern tissue-resident ILC3 subset function and identity

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

Setd2 determines distinct properties of intestinal ILC3 subsets to regulate intestinal immunity

The Interaction Between Lymphoid Tissue Inducer-Like Cells and T Cells in the Mesenteric Lymph Node Restrains Intestinal Humoral Immunity.

Context-dependent role of group 3 innate lymphoid cells in mucosal protection

The Transcription Factor ThPOK Regulates ILC3 Lineage Homeostasis and Function During Intestinal Infection.

Functions of Group 2 Innate Lymphoid Cells in Tumor Microenvironment

T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

The Transcription Factor GATA3 is Critical for the Development of All IL-7Rα-expressing Innate Lymphoid Cells.

GATA-3 regulates the development of ILC3 subsets at multiple stages (LYM2P.721)

Enrichment of type I interferon signaling in colonic group 2 innate lymphoid cells in experimental colitis

Lymphotoxin-dependent Control of Innate Immune Responses in the Gut

IL-18/IL-18R Signaling is Dispensable for ILC Development but Constrains the Growth of ILCP/ILCs.

Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut

Retinoid X Receptor Gamma Dictates the Activation Threshold of Group 2 Innate Lymphoid Cells and Limits Type 2 Inflammation in the Small Intestine.